News About: Pharm. Affairs
Decrease trend of antibiotics usage
The amount of antibody prescriptions of Korean medical institutions, which raised concerns of excessive prescriptions of antibodies, has shown a decrease rate. The last year’s prescriptions were KRW 1.0868 trillion, i...
Health insurance prices of 82 registered pharmaceutical products decrease from the 1st
Health insurance ceiling prices of 80 registered pharmaceutical products, such as Mabthera Inj, a target agent, will be reduced from the 1st of the next month.
The reduced price of Baraclude, a chronic hepatitis B tr...
Osteoporosis market getting ready for launches of drinkable and effervescent drugs
In the domestic osteoporosis market concentrating on purified and injection products, products increasing administration convenience are getting ready to be launched.
According to the pharmaceutical industry on the 2...
Amosartan ranks the top in the KRW 150 billion improved drug market for 4 years
Hanmi Pharm’s Amosartan Tab 5/50mg has kept the top position in the improved drug market for 4 consecutive years.
DailyPharm analyzed actual outputs of the top 18 improved drugs for the past 4 years.
Last year, the ...
‘Soliris,’ a PNH treatment, applied by ‘Refund RSA’ next month
The only PNH(paroxysmal nocturnal hemoglobinuria) treatment, ‘Soliris,’ will be applied by RSA from October.
According to the industry concerned on the 18th, Soliris(eculizumab), which will face the ending of its ref...
“Hallow market” with unnecessary large-scale pharmaceutical patent expirations
The pharmaceutical industry have not been satisfied even with patent expirations of large original pharmaceutical products. In particular, it was indicated that separation between the management and medical representa...
GSK’s Cervarix became the top of ‘Female VaccineThe GSK’s(Yoo-seok Hong, Korean Branch President) uterine cervical cancer preventive vaccines, ‘Cervarix,’ has acquired additional approval for indication of vaginal intra-epith...
|
Large pharmaceutical product production slump
While the slowdown effect of overall pharmaceutical product production has lasted, production of large complete pharmaceutical products has not been able to get away from the slowdown. It was interpreted as reflection...
The ‘PPI medicine’ market exceeded KRW 300 billion
Usage of PPI(proton-pump inhibitor) drugs, well-known reflux esophagitis treatments, is continuously increasing every year.
The annual increase rate was 9.7% for the past 5 years, and their prescriptions exceeded KRW...
The GLP-1 analogue insurance standard is largely improved
The GLP(glucagon-like peptide)-2 analogue, a diabetes treatment, has met a chance to be expanded in prescriptions by improvement of the health insurance standard.
The Ministry of Health and Welfare, on the 15th, has ...
